Cumberland Pharmaceuticals CPIX Debt Issuance Cost Amortization
Debt Issuance Cost Amortization at other companies
Other financials
Where this comes from
Reported directly by Cumberland Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCosts.
The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cumberland Pharmaceuticals's debt issuance cost amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cumberland Pharmaceuticals's debt issuance cost amortization?
- Cumberland Pharmaceuticals (CPIX) reported debt issuance cost amortization of $5.17K in Q1 2026.
- How has Cumberland Pharmaceuticals's debt issuance cost amortization changed year-over-year?
- Cumberland Pharmaceuticals's debt issuance cost amortization decreased by 3.5% year-over-year, from $5.36K to $5.17K.
- What is the long-term trend for Cumberland Pharmaceuticals's debt issuance cost amortization?
- Over 4 years (2021 to 2025), Cumberland Pharmaceuticals's debt issuance cost amortization has grown at a -9.2% compound annual growth rate (CAGR), from $34.05K to $23.19K.
- What does debt issuance cost amortization mean?
- Non-cash amortization of capitalized costs incurred to issue debt (underwriting fees, legal costs, SEC filing fees).